Abstract. Autophagy has been reported to be involved in the occurrence and development of pancreatic cancer. However, the mechanism of autophagy-associated non-coding RNAs (ncRNAs) in pancreatic cancer remains largely unknown. In the present study, microarrays were used to detect differential expression of mRNAs, microRNAs (miRNAs), long ncRNAs (lncRNAs) and circular RNAs (circRNAs) post autophagy suppression by chloroquine diphosphate in PANC-1 cells. Collectively, 3,966 mRNAs, 3,184 lncRNAs and 9,420 circRNAs were differentially expressed. Additionally, only two miRNAs (hsa-miR-663a-5p and hsa-miR-154-3p) were underexpressed in the PANC-1 cells in the autophagy-suppression group. Furthermore, miR-663a-5p with 9 circRNAs, 8 lncRNAs and 46 genes could form a prospective ceRNA network associated with autophagy in pancreatic cancer cells. In addition, another ceRNA network containing miR-154-3p, 5 circRNAs, 2 lncRNAs and 11 genes was also constructed. The potential multiple ceRNA, miRNA and mRNA associations may serve pivotal roles in the autophagy of pancreatic cancer cells, which lays the theoretical foundation for subsequent investigations on pancreatic cancer.
Introduction
Pancreatic cancer is a highly aggressive and fatal malignancy, with stably high incidence and mortality for the past 30 years globally (1) (2) (3) (4) . Patients with pancreatic adenocarcinoma account for ~85% of all patients with pancreatic cancer and have a poor prognosis, compared with patients with other common solid tumors (2, (5) (6) (7) (8) (9) . Pancreatic cancer is primarily treated through surgical resection, whereas postoperative patients and patients with advanced disease are frequently subjected to adjuvant therapies with radiotherapy, chemotherapy, and a combination of radiotherapy and chemotherapy that are associated with high recurrence rates and poor treatment effectiveness (10) . The recent development of and research into molecular targeted drugs have great significance for the early diagnosis and prognosis of malignant tumors, and have ushered a new era of tumor therapy (11) (12) (13) (14) (15) . However, the overall treatment effect of these drugs remains poor, and further investigation is required (16) .
Autophagy is a process by which eukaryotic cells undergo self-degradation of intracellular damaged macromolecular proteins and organelles (17, 18 ). Autophagy at the physiological level is necessary to maintain the stability of the internal environment, and the occurrence of a variety of diseases, including inflammation, tumors and degenerative diseases, is frequently accompanied by an abnormal autophagic level (19) (20) (21) (22) (23) (24) (25) . Currently, well-characterized, autophagy-associated proteins include Beclin 1, microtubule-associated-protein-1-light-chain-3 (LC3) and P62, and well-studied pathways include mechanistic target of rapamycin (mTOR) and phosphoinositide 3-kinase (PI3K) pathways (26, 27) .
Recently, the important role of autophagy in tumors has been recognized (19, 28) . Studies demonstrated that pancreatic cancer cells have an increased autophagy level, compared with other tumor cells (29) (30) (31) (32) (33) (34) . The growth of PDAC had a distinct dependence on autophagy in vivo and in vitro (35) . Inhibition of autophagy is effective for the treatment of pancreatic cancer through animal experiments (36) . Another study revealed that autophagy can be activated by gemcitabine and ionizing radiation in the treatment of pancreatic cancer cells, and activated autophagy serves a role in cancer suppression (37) . However, whether autophagy promotes the occurrence, development and prognosis of pancreatic cancer is controversial (38) . Therefore, the role of autophagy in the occurrence, development, prognosis and treatment of pancreatic cancer and its mechanism requires further examination.
mRNA is a single-stranded RNA that is transcribed using one of the DNA chains as the template and carries the genetic information that guides protein synthesis. Thus, mRNA occupies an important position in the heredity dogma (39) . mRNA serves a key role in various human diseases and is involved in autophagy pathways (40, 41) ; for example, signal transducer and activator of transcription 3 could inhibit autophagy in pancreatic cancer cells (42) and ubiquitin specific peptidase 1 regulates autophagy by targeting Unc-51 like autophagy activating kinase 1 (ULK1) (43) . Non-coding RNA (ncRNA) refers to RNA that does not encode a protein and includes ribosomal RNA (rRNA), transfer RNA (tRNA), small nuclear RNA (snRNA), long ncRNA (lncRNA), microRNA (miRNA) and circular RNA (circRNA) (44) (45) (46) (47) (48) (49) (50) . The involvement of lncRNAs and miRNAs in cancer has been studied intensively, whereas the potential significance of circRNAs in tumors has attracted attention over the last two years (51) . The post-transcriptional levels of circRNAs serve a notable regulatory role in gene expression (52) . Furthermore, the sponge effect of circRNAs on miRNAs is an important mechanism (53) . circRNAs can contain multiple miRNA binding sites, and attract miRNAs effectively to reduce miRNA-mediated mRNA inhibition (54) (55) (56) . Based on the interaction between these three types of ncRNAs and the current research status in pancreatic cancer, it was considered that an investigation of the effect of lncRNAs and circRNAs as competitive endogenous RNAs (ceRNAs) on the targeting of miRNAs in the development of pancreatic cancer is beneficial.
Recently, the number of autophagy-associated lncRNAs has been determined to be limited (57) (58) (59) (60) , and investigations on circRNAs and their associations with autophagy have not been reported to date. However, due to autophagy being involved in the occurrence and development of a variety of diseases, including breast (61, 62) , gastric (63) and lung cancer (64) , in the present study, the human pancreatic cancer cell line PANC-1 and gene chip technology was used to detect differential expression of mRNAs, miRNAs, lncRNAs and circRNAs under different autophagy levels, and to investigate the genes associated with autophagy in pancreatic cancer and their underlying molecular mechanisms.
Materials and methods
Cell treatment. The human pancreatic cancer cell line PANC-1 was obtained from the Cell Laboratory of Chinese Academy of Sciences (Shanghai, China) and cultured in complete Dulbecco's modified Eagle's medium (DMEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) at 37˚C. Due to chloroquine diphosphate being frequently used as a classic autophagic inhibitor (65, 66) , the following concentration gradient of chloroquine diphosphate (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) was designed as recommended by the manufacturer's protocols: 0, 25, 50, 75 and 100 µM. When the number of cells in the culture bottle grew to ~5x10 6 , the original medium was replaced by a complete DMEM containing chloroquine diphosphate. Following treating the cells for 12 h at 37˚C with the drug, the cellular proteins were immediately extracted using Radioimmunoprecipitation Assay Lysis Buffer (Beyotime Institute of Biotechnology, Haimen, China).
Western blotting. The lysis solution (radioimmunoprecipitation assay buffer:phenylmethylsulfonyl f luoride; 100:1, Beyotime Institute of Biotechnology) was prepared. The protein concentration in the lysate was determined with a bicinchoninic acid kit (Beyotime Institute of Biotechnology), according to the manufacturer's instructions. Western blotting was performed according to routine procedures, and conducted with a 12% separating gel and a 5% stacking gel. A total of 20 µg protein was added to the glue holes. The electrophoresis condition was set to 120 Ma for 1 h. Following the electrophoresis, the protein was transferred to the polyvinylidene (PVDF) membrane (Beyotime Institute of Biotechnology). Subsequently, the PVDF membrane was placed into the Bull Serum Albumin blocking buffer (Beyotime Institute of Biotechnology) for shaking at 37˚C for 2 h. Primary antibodies were incubated at 4˚C overnight and secondary antibodies were incubated at room temperature for 2 h. The primary antibodies were LC3 β-specific rabbit polyclonal (1:1,000; cat. no. 18725-1-AP) and P62 mouse monoclonal antibodies (1:2,000; cat. no. 66184-1-Ig), which represented the state of autophagy, and the GAPDH horseradish peroxidase-labeled internal reference antibody (1:10,000; cat. no. HRP-60004), andhe secondary antibodies used were goat anti-mouse IgG (H+L), allopregnanolone conjugate (1:1,000; cat. no. SA00002-1) (all from ProteinTech Group, Inc., Chicago, IL, USA). The gray scale values of the protein bands from the raw image were determined using the ImageJ 1.48 (National Institutes of Health, Bethesda, MD, USA) and the formula Final gray scale value (G) = [G x (target band) -G x (background)] / [G x (internal reference band of the group) -G x (background)]. The data were analyzed using SPSS software 22 (SPSS, Inc., Chicago, IL, USA), and the results were plotted using the GraphPad Prism 5 software (GraphPad Software, Inc., La Jolla, CA, USA).
Sample grouping. Based on the results of the western blotting experiment, the human pancreatic cancer PANC-1 cells treated with 100 µM chloroquine diphosphate were selected as the autophagic inhibition group, and the cells cultured in normal DMEM medium were selected as the control group. Subsequent experiments were compared between the autophagic inhibition group and the control group. Following chloroquine diphosphate treatment, total RNA was prepared using the TRIzol ® reagent (Beyotime Institute of Biotechnology) with three replicates per group.
ceRNA microarray and detection, and statistical analysis of the miRNA chip results. The quality control for the gene analyses in the present study was performed by Shanghai Biotechnology Corporation (Shanghai, China). The starting sample of the microarray test was total RNA, which was analyzed with the NanoDrop ND-2000 spectrophotometer and the Agilent Bioanalyzer 2100 (Agilent Technologies, Inc., Santa Clara, CA, USA) to conduct the quality control assay. Only RNA samples that passed the quality control proceeded to the subsequent microarray experiments. The qualifying sample standards were that the RNA integrity number of each sample was ≥7.0 and that the 28S/18S was ≥0.7.
The ceRNA microarray detection assay included the detection of three types of RNA (lncRNA, circRNA and mRNA). The cutoff values of the differentials were all set to a fold change (FC)>2 or FC<0.5 and P<0.05. The assays and data analyses are described below. The analyses primarily included the normalization of raw data, sample association analysis, screening of genes with differential expression, Gene Ontology (GO) enrichment analysis of the differentially-expressed mRNAs, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, PANTHER pathway analysis of the differentially-expressed mRNAs, prediction of lncRNA and circRNA target genes, and prediction of lncRNA and circRNA adsorption of miRNAs. GO and KEGG pathway were generated by DAVID (https://david.ncifcrf.gov/) while PANTHER was analyzed using the WebGestalt 2017 tool (http://www.webgestalt.org/option.php). The clinical roles of genes were analyzed through the online database of Gene Expression Profiling Interactive Analysis (GEPIA; http://gepia.cancer-pku.cn/) Which is based on the data obtained from The Cancer Genome Atlas and GTEx. The miRNA microarray analyses primarily included the normalization of raw data, sample association analysis, screening of differentially-expressed miRNAs and prediction of miRNA target genes, which was predicted by 12 online miRNA target prediction databases [DIANA-microTv4.0 (67), DI A NA-m icroT-CDS (68), m i Randa-rel2010 (69), m i rbr idge (70) , m i R DB4. 0 (71), m i R Map (72) , miRNAMap (73) 
RNA extraction and Real-time fluorescent quantitative PCR (RT-qPCR).
According to the user guides provided by the manufacturer, the total RNA of tissues was extracted using an E.Z.N.A.
® FFPE RNA kit (Omega Bio-Tek, Inc., Norcross, GA, USA). The complementary DNA (cDNA) was reverse transcribed through the kit of miRNA First Strand cDNA Synthesis [Tailing Reaction (79, 80) ] (Sangon Biotech Co., Ltd., Shanghai, China), and RT-qPCR was conducted by applying a MicroR NAs qPCR kit [SYBR ® Green method (81,82)] (Sangon Biotech Co., Ltd.), according to the manufacturer's protocols, on an ABI Prism 7500 (Applied Biosystems; Thermo Fisher Scientific, Inc.). The temperature of pre-denaturation and denaturation were both set at 95˚C, and the temperature of annealing/extension was set at 60˚C. Pre-denaturation was conducted for 10min, denaturation for 15 sec and annealing/extension for 60 sec. The number of cycles was set to 40. Subsequently, the expression of miRNA relative to U6 was calculated via the 2 -ΔΔCq method on identical samples (83) . The PCR primers included: i) miR-663a-5p for wa rd, 5'-ATAG G CG G G G CG CCG CG G GAC-3'; ii) miR-154-3p forward, 5'-CCGGGAATCATACACGGTTGA CCTATT-3'; and iii) U6 forward and universal PCR reverse primer were attached to the kits. Their primer sequences are Statistical analysis. The data of GEO and RT-qPCR were calculated using SPSS 22 software for mean and standard deviation (SD). Continuous data are presented as mean ± SD. The forest plots were produced by Stata 12.0. The heterogeneity test was used to analyze the existence of heterogeneity and the source of the occurrence of heterogeneity (I 2 >50% or P<0.05 is the existence of heterogeneity). Funnel plots were used for the analysis of publication bias. The comparison between the two groups was performed using two-sample Student's t-test. The method for differential gene expression analysis in GEPIA was one-way analysis of variance, using pathological stage as variable for calculating differential expression. GEPIA performs overall survival analysis based on gene expression. GO analysis was performed in DAVID tool which used Fisher's exact test and the techniques of Kappa statistics (84) . PANTHER analysis was performed in WebGestalt, which used Hypergeometric and Fisher's exact tests. P<0.05 was considered to indicate a statistically significant difference.
Results
Autophagy following chloroquine diphosphate treatment. The present study design of the whole investigation is depicted in Fig. 1 . The LC3-II expression level was significantly reduced in the control group, compared with the group treated with 25 or 100 µM chloroquine diphosphate (P<0.05). However, the P62 expression level was significantly increased in the group treated with 100 µM chloroquine diphosphate, compared with the control group or the groups treated with 25, 50, 75 or 100 µM chloroquine diphosphate (P<0.05). Thus, the 100 µM concentration of chloroquine diphosphate had the greatest significant inhibitory effect on autophagy in human pancreatic cancer PANC-1 cells (Fig. 2) .
Quality control of samples for the ceRNA microarray and miRNA microarray chips. Electrophoresis of the RNA samples indicated that the RNA integrity number of each sample was ≥7.0 and that the 28S/18S was ≥0.7, which reached the qualifying sample standards. Thus, the samples were qualified for use in the subsequent experiments.
Assays to identify differentially-expressed mRNAs, lncRNAs, circRNAs and miRNAs. The ceRNA microarray results determined 3,966 differentially-expressed mRNAs in total. The expression levels of 2,445 mRNAs in the PANC-1 cells from the chloroquine diphosphate treatment group (autophagy suppression group) were downregulated and 1,521 mRNAs were upregulated, compared with the control group (Fig. 3) . Additionally, 3,184 differentially-expressed lncRNAs were observed, including 1,637 downregulated and 1,547 upregulated (Fig. 4 ), whereas 9,420 circRNAs were determined to be differentially expressed, including 4,223 downregulated and 5,197 upregulated (Fig. 5) . The miRNA microarray results demonstrated that the expression levels of two miRNAs (hsa-miR-663a-5p and hsa-miR-154-3p) were underexpressed in the PANC-1 cells in the autophagy-suppression group, compared with the control group. No upregulated miRNA was determined. The cutoff values of the aforementioned differentials were all set to a fold change>2 or FC<0.5 and P<0.05.
Bioinformatics analysis of the f unctions of the differentially-expressed mRNAs.
GO and KEGG pathway analyses were performed using the DAVID database. The 3,966 differentially-expressed mRNAs in the chloroquine diphosphate treatment group (autophagy suppression group), compared with the control group, were subjected to bioinformatics analysis of their functions. The results demonstrated that these genes were concentrated in the biological processes, molecular functions and cellular components categories in the GO analysis (Table I) , and were involved in the regulation of multiple KEGG signaling pathways including pathways in cancer and the mitogen-activated protein kinase signaling pathway (Table II) . Of these functions, the involvement of the autophagy-associated pathway (Autophagy) was notable. Additionally, the differentially-expressed genes in this pathway included a number of recognized autophagy-associated genes, including autophagy-related 12 (ATG12), GABA type A receptor associated protein like 1 (GABARAPL1) and ULK2, which were differentially expressed in the present ceRNA microarray results also (Fig. 6) . Following analyzing the clinical roles of the three genes via the Gene Expression Profiling Interactive Analysis online database, which is based on the data obtained from The Cancer Genome Atlas and GTEx, it was determined that the expression of ATG12 was upregulated in pancreatic cancer tissue, compared with non-tumor tissue. Furthermore, high expression of ATG12 was associated with significantly reduced survival time (P<0.01). Notably, the expression of ATG12, GABARAPL1 and ULK2 were increased in pancreatic cancer, compared with the control group (Fig. 6 ). These results validated that these autophagy-associated genes were involved in the onset and progression of pancreatic cancer.
Prediction of target genes of the differentially-expressed miRNAs and the bioinformatics analysis of their functions.
These results were integrated with the differentially-expressed mRNAs that were actually measured. The co-expressed genes were subjected to GO and KEGG pathway analyses using the DAVID database.
Prediction of miR-663a-5p ta rget genes a n d bioinformatics analysis of their functions. A total of 1,726 target genes of miR-663a-5p were detected by at least 6 platforms using the aforementioned 12 online miRNA target gene prediction databases. Following cross-checking with the differentially-expressed genes in the autophagy suppression group derived from chloroquine diphosphate treatment, 462 co-expressed genes were obtained (Fig. 7) . These genes were subjected to GO and KEGG pathway analyses. The results demonstrated that these genes were concentrated in the biological processes, molecular functions and cellular components categories in the GO analysis (Fig. 8A , Table III ) and were involved in the regulation of multiple KEGG signaling pathways (Table III) , including the aldosterone-regulated sodium reabsorption and Wnt signaling pathways ( Fig. 8B-D) . However, there were no significant pathways determined by PANTHER analysis (P>0.05).
Prediction of miR-154-3p target genes and bioinformatics analysis of their functions.
A total of 294 target genes of miR-154-3p were detected by at least 6 programs using the aforementioned 12 online miRNA target gene Figure 4 . Scatterplots of the differentially-expressed lncRNAs following autophagy being inhibited. Differentially-expressed lncRNAs were screened with a microarray following autophagy being inhibited with chloroquine diphosphate at a concentration of 100 µM. lncRNA, long non-coding RNA. Figure 5 . Scatterplots of the differentially-expressed circRNAs following autophagy being inhibited. Differentially-expressed circRNAs were screened with a microarray following autophagy being inhibited with chloroquine diphosphate at a concentration of 100 µM. circRNA, circular RNA. prediction databases. Following cross-checking with the differentially-expressed genes in the autophagy suppression group derived from chloroquine diphosphate treatment, 294 co-expressed genes were obtained (Fig. 9 ). These genes were subjected to GO and KEGG pathway analyses. The results demonstrated that these genes were concentrated in the biological processes, molecular functions and cellular components categories in the GO analysis (Fig. 10A , Table IV) , and were involved in the insulin signaling, Forkhead Box O (FoxO) signaling and proteoglycans in cancer pathways (Table IV , Fig. 10B-D) . Additionally, the results of PANTHER analysis revealed these genes were concentrated in a numbered of pathways, including the p53 pathway by glucose deprivation and the classical gastrin cholecystokinin receptor (CCKR) signaling map (Table V, Fig. 11 ).
Prediction of ceRNAs of the differentially-expressed miRNAs.
Different online platforms were used to predict the target genes of the differentially-expressed miRNAs. The target circRNAs and lncRNAs of the differentially-expressed miRNAs were searched based on the prediction of the target miRNAs of the differentially-expressed circRNAs and lncRNAs revealed by microarray detection, and the differentially-expressed miRNAs that were detected. The ceRNAs that were negatively associated with the expression of the miRNAs were selected. Prediction of ceRNAs of miR-663a-5p. A total of 21 differentially-expressed circRNAs that targeted miR-663a-5p were determined, of which nine (hsa_circ_0003176, hsa_circ_0048579, hsa_circ_0063706, hsa_circ_0071922, hsa_circ_0078989, hsa_circ_0079319, hsa_circ_0083080, hsa_circ_0089643 and hsa_circ_0090372) indicated negative associations with miR-663a-5p expression. hsa_circ_0071922 had the highest number of binding sites for miR-663a-5p, with six. Simultaneously, 45 differentially-expressed lncRNAs that targeted miR-663a-5p were determined, of which 8 lncRNAs (RP11-59C5.3, RP13-516M14.8, RP11-196G18.24, AJ006995.3, AC024560.2, PPP1R1C, LINC00595 and HAGLROS) were negatively associated with miR-663a-5p expression. All of these lncRNAs had one miR-663a-5p binding site (Table VI) . Subsequently, 144 common predicted targets from at least 8 among 12 programs were selected to overlap with the 3,966 differentially-expressed genes following autophagy inhibition. Collectively, 46 potential targets were determined. Thus, a ceRNA hypothesis figure with miR-663a-5p, 9 circRNAs, 8 lncRNAs and 46 genes was depicted in Fig. 12 .
Prediction of ceRNAs of miR- 154-3p . A total of 6 differentially-expressed circRNAs that targeted miR-154-3p were determined, of which five (hsa_circ_0000156, hsa_circ_0004089, hsa_circ_0006461, hsa_circ_0015157 and hsa_circ_0038665) indicated a negative association with miR-154-3p expression. All of these circRNAs had two miR-154-3p binding sites. Simultaneously, 16 differentially-expressed lncRNAs that targeted miR-154-3p were determined, of which two (RP11-686O6.1 and LINC01140) were negatively associated with miR-154-3p expression. These lncRNAs had one miR-154-3p binding site (Table VI) . Similarly to miR-663a-5p, 67 common predicted targets of miR-154-3p from at least 8 among 12 platforms were collected, and then they were intersected into the 3,966 differentially-expressed genes following autophagy suppression. Eventually, 11 potential targets were collected. Hence, a ceRNA hypothesis network with miR-154-3p, 5 circRNAs, 2 lncRNAs and 11 genes was presented (Fig. 13) . however, heterogeneity existed (I 2 =63.6%; P=0.011; Fig. 14B ). Sensitivity analysis and publication bias of miR-663a-5p were depicted in Fig. 14C . The combined SMD values of miR-154-3p was -0.434 (95% CI, -1.079-0.212; Fig. 15A )], which indicated that miR-154-3p had low expression in pancreatic cancer tissues; however, heterogeneity existed (I²=76.0%; P=0.001; Fig. 15B ). Sensitivity analysis and publication bias of miR-154-3p were depicted in Fig. 15C . 
Meta-analysis of miR-663a-5p and miR-154-3p expression based on RT-qPCR and GEO data. A comprehensive analysis

Discussion
Pancreatic cancer is one of the common malignancy types of the digestive system. Due to the lack of an effective early diagnosis, numerous patients are already in the advanced stage of the cancer when diagnosed (85) . Currently, pancreatic cancer treatment remains dominated by surgical resection, which has a low five-year survival rate (86) (87) (88) . Therefore, there is an urgent requirement for a series of effective markers for pancreatic cancer to change the current status of the (91) and breast cancer (92) . Over the past two years, the extensively investigated ncRNAs, including lncRNAs and glucose deprivation miRNAs, and circRNAs, which were newly revealed to have similar regulatory functions, particularly to miRNAs, were indicated to also serve crucial roles (44, (93) (94) (95) (96) (97) . Abnormal expression of a large number of miRNAs has been determined in malignant tumor tissues (98-100). For example, it has been reported that miR-221/222 and miR-15b serve a role in causing malignant tumors (101) . Additionally, it was determined that miR-451 and miR-126 have an abnormal expression in lung cancer (102) , and the targeted delivery of miRNA therapeutics was a promising strategy for cancer (103) . This abnormal expression pattern affects the occurrence, development and prognosis of the tumor by directly regulating the biological functions of the targeted mRNAs (102, (104) (105) (106) (107) (108) (109) (110) (111) (112) . Studies have demonstrated that a variety of miRNAs exhibit abnormal expression patterns in pancreatic cancer cells that affect the occurrence, development and prognosis of pancreatic cancer; for example, the upregulated expression of miR-10b, miR-21, miR23a and miR-27a in pancreatic cancer affects cell growth, proliferation and apoptotic metastasis by targeting programmed cell death 4, BTG anti-proliferation factor 2, neural precursor cell expressed, developmentally downregulated 4-like, phosphatase and tensin homolog, HIV-1 Tat interactive protein 2 and p16 (113) (114) (115) (116) (117) .
With the increased understanding of the regulatory mechanism of ncRNAs, ceRNAs have attracted increasing attention as important regulators of miRNA activity. ceRNA refers to lncRNAs and circRNAs that suppress miRNA expression through targeted binding to the miRNA, and thus regulate its activity, which affects the development, progression and prognosis of tumors (118) (119) (120) . Studies have indicated that lncRNA-metastasis associated lung adenocarcinoma transcript 1 can target miR-124 to reduce its expression and activate cyclin-dependent kinase 4, thereby accelerating the progression of breast cancer (121) (122) (123) . A recent study on pancreatic cancer demonstrated that lncRNA-urothelial cancer associated 1 was overexpressed in pancreatic cancer tissues and reduced miR-135a expression by adsorbing it, thereby inhibiting genes associated with tumor growth and metastasis (124) . These examples highlight the significance of the interactions among lncRNAs, miRNAs and mRNAs for cancer diagnosis and treatment. Therefore, our aim was to mine pancreatic cancer autophagy-associated ceRNAs and miRNAs through assays with ceRNA and miRNA microarrays, respectively, to reveal their targets using bioinformatics methods, construct ceRNA, miRNA and mRNA pathways, predict the potential molecular mechanisms of the ceRNA, miRNA and mRNA pathways in the autophagy of pancreatic cancer, and provide novel ideas and directions for further studies of pancreatic cancer.
Firstly, the differentially-expressed mRNAs were analyzed. The results demonstrated that PANC-1 cells treated with chloroquine diphosphate had multiple differentially-expressed mRNAs, compared with the control group, using the FC value FC>2 or FC<0.5 as the threshold. The bioinformatics analysis of these genes indicated that as the autophagic level changed, the differentially-expressed genes were primarily concentrated in tumor-associated and pancreatic cancer-associated pathways. Notably, the autophagy-associated pathway, in which three genes (ATG12, GABARAPL1 and ULK2) were abnormally expressed when the autophagic level, was inhibited. ATG12 Figure 12 . ceRNA network of miR-663a-5p. The predicted ceRNA of miR-663a-5p included 9 upregulated circRNAs, 8 upregulated lncRNAs, miR-663a-5p and 46 differentially-expressed mRNA, which were differentially expressed in the ceRNA microarray results as well. Nodes in green, yellow, red and blue represent circRNAs, lncRNAs, miRNA-663a-5p and mRNAs, respectively. miR, microRNA; circRNA, circular RNA; lncRNA, long non-coding RNA; ceRNA, competitive endogenous RNA. Figure 13 . ceRNA network of miR-154-3p. The predicted ceRNA of miR-154-3p included 5 upregulated circRNAs, 2 upregulated lncRNAs, miR-154-3p and 11 differentially-expressed mRNA, which were differentially expressed in the ceRNA microarray results as well. Nodes in yellow, green, red and blue represent circRNAs, lncRNAs, miRNA-154-3p and mRNAs, respectively. The arrows indicate the direction of transcription. miR, microRNA; circRNA, circular RNA; lncRNA, long non-coding RNA; ceRNA, competitive endogenous RNA.
is an autophagy-related protein that has been demonstrated to function as a key autophagy-associated target gene regulated by miR-23b, and suppression of ATG12 significantly increased the radiosensitivity of pancreatic cancer cells, whereas the miR-23b-induced radiosensitivity was eliminated by ATG12 overexpression (125) . Studies indicated that ULK served an important role in the autophagy process (126) (127) (128) . ULK2 and ULK1 are highly homologous, functionally complementary and indispensable for affecting autophagy (129) (130) (131) . GABARAPL1 is considered as a target of miR-195 and regulates the proliferation, migration, angiogenesis and autophagy of endothelial progenitor cells (132). These three genes (ATG12, GABARAPL1 and ULK2) may serve pivotal roles in the autophagy suppressed by chloroquine diphosphate in pancreatic cancer cells.
To determine relevant miRNAs and elucidate their potential regulatory mechanisms in the autophagy of pancreatic cancer, differentially-expressed miRNAs were analyzed and their target genes were predicted. Subsequently, the results were compared with the target genes detected in the microarray analysis. The co-expressed genes were considered the putative target genes regulated by the abnormally-expressed miRNAs during the autophagy process in pancreatic cancer cells. Bioinformatics analyses were performed on these target genes to identify the signaling pathways and biological processes that were regulated. The results demonstrated that the expression of miR-663a-5p and miR-154-3p was downregulated in the PANC-1 cells treated with chloroquine diphosphate, compared with the control group. miR-663a-5p expression in pancreatic cancer tissues is significantly downregulated and negatively associated with eukaryotic translation elongation factor 1α 2 (eEF1A2) expression due to miR-663 reducing the proliferation and invasion of pancreatic cells by directly targeting eEF1A2 in vitro and in vivo (133) . Additionally, miR-663a-5p has been reported to have a low expression in hepatocellular carcinoma (134) , non-small cell lung cancer (135) and colorectal cancer (136) . Similarly, the present comprehensive analysis indicated that the expression of miR-663a-5p was downregulated in pancreatic ductal adenocarcinoma (PDAC). In the present study, the bioinformatics analyses indicated that the putative autophagy pathways in the pancreatic cancer cells regulated by miR-663a-5p included the aldosterone-regulated sodium reabsorption, Wnt signaling, basal cell carcinoma, fatty acid biosynthesis and PI3K-Akt signaling pathways, of which the Wnt signaling and PI3K-Akt signaling pathways were considered to have a function in the regulation of autophagy (137) (138) (139) (140) (141) (142) (143) . Currently, whether miR-154-3p is involved in the biological processes of pancreatic cancer cells, including occurrence, development, prognosis and autophagy, remains unknown; however, miR-154-3p was reported to be expressed at a low level in colorectal cancer and was associated with the degree of malignancy of colorectal cancer (144) . Similarly, miR-154-3p exhibited low expression in breast cancer and affected the treatment outcome of breast cancer by regulating E2F transcription factor 5 (145) . Additionally, the present comprehensive analysis indicated that the expression of miR-154-3p was downregulated in PDAC. Furthermore, the bioinformatics analyses indicated that the putative autophagy pathways in the pancreatic cancer cells regulated by miR-154-3p included the insulin signaling pathway, FoxO signaling, mitogen-activated protein kinase signaling, ErbB signaling, p53 pathway by glucose deprivation and CCKR signaling map pathways. Activation of insulin like growth factor 1 receptor (IGF-1R) signaling antagonizes the decrease in cell viability of human disc cells through the suppression of apoptosis and enhancement of autophagy (146) . IGF-1R increases cell viability during hypoxia, which may be dependent on promoting autophagy by suppressing the PI3K/Akt/mTOR signaling pathway (147) . The present study demonstrated that a number of genes, including suppressor of cytokine signaling 1 (SOCS1), plasma membrane intrinsic protein 3 (PIP3) and serine/threonine protein phosphatase type 1 α (PP1), which were involved in the insulin signaling pathway, were abnormally expressed when the autophagic level was decreased. Overexpression of SOCS1 suppressed the PI3K/PIP3/Akt signaling pathway with the subsequent PP1 activation, which has been demonstrated to induce autophagy (148, 149) . Autophagy is inhibited under the condition of oxygen-glucose deprivation (150) . Therefore, we hypothesized that miR-154-3p influences the key genes in the insulin signaling or p53 pathways by glucose deprivation, thereby affecting autophagy. Additionally, due to the involvement of CCKR signaling in pancreatic enzyme secretion (151, 152) , miR-154-3p may serve a key role in the secretion process. Therefore, the data in the present study will provide novel directions for the investigation of pancreatic cancer and its autophagy.
To elucidate which genes inhibited the miRNAs regulating the autophagy of pancreatic cancer cells through competitive binding, potential target associations between circRNA and miRNA, and between lncRNA-miRNA were predicted based on the competitive expression of ceRNA and miRNA. When these results were combined with the differentially-expressed circRNAs and lncRNAs under different autophagic levels detected by the microarrays, numerous ceRNAs that exhibited target associations with miR-663a-5p and miR-154-3p, and negative associations with the expression of the targeted miRNAs under the same changes in the autophagic level were determined. AC024560.2 is an effective lncRNA residing on chromosome 3 that can be used to predict the metastasis of early cervical cancer to lymph nodes (153) . In the present study, AC024560.2 was determined to competitively bind to miR-663a-5p and thus regulate the autophagic level of pancreatic cancer cells by inhibiting the expression of this miRNA. For the other ceRNAs, their associations with tumors have not been reported, and further investigations are required.
Since the molecular mechanisms of tumor occurrence and development are complex and the numerous different physiological processes, including differentiation (154) and aging (155) , are frequently accompanied by an aberrant autophagic level (156, 157) , it is not surprising that the interference of autophagy is determined to be one of the therapeutic methods for tumors. The growth of PDAC could be repressed by hydroxychloroquine in vivo and in vitro (158) . PDAC was dependent on autophagy and the use of an autophagy inhibitor may become the breakthrough point of treatment (35) . However, in the treatment of PDAC with gemcitabine, a high concentration of gemcitabine is required following adding autophagy inhibitors (37) . Therefore, autophagy may serve a dual role in the development of PDAC. Investigating the ceRNA network following inhibiting autophagy, of which these genes may serve role in inhibiting autophagy or promoting autophagy, will provide novel ideas for determining new ways to treat pancreatic cancer. On this basis, the biological function and action mechanism of these two miRNAs will be investigated in further studies.
In summary, the miRNAs that were significantly associated with the autophagy of pancreatic cancer included miR-663a-5p and miR-154-3p. These miRNAs were used as the intermediate regulatory sites, upstream to which multiple putative ceRNAs, including AC024560.2, were present and downstream to multiple targeted regulatory genes, including ATG12 and ULK1. The expression of these miRNAs was regulated through ceRNA, miRNA and mRNA interactions, which could serve important regulatory roles in pancreatic cancer autophagy.
In conclusion, autophagy serves an important role in the development and progression of various malignant tumor types, including lung (159), gastric (160) and renal cancer (161) . The investigation of differentially-expressed genes in pancreatic cancer cells under different autophagic levels not only clarifies the regulatory mechanism of the autophagic process in pancreatic cancer cells, but also provides novel ideas for the effective diagnosis and treatment of pancreatic cancer. In the present study, microarray technology was employed to confirm that the change in the autophagic level of pancreatic cancer cells was accompanied by various differentially-expressed genes. Following establishing multiple ceRNA, miRNA and mRNA associations, there is more reason to consider that these genes will serve important roles in the diagnosis and treatment of pancreatic cancer, and thus lay the theoretical foundation for subsequent investigations on pancreatic cancer while indicating new research directions. Subsequently, the regulatory functions of these genes at the cellular and tissue levels will be investigated and their specificity and accuracy will be further validated through a series of in vivo and in vitro experiments.
